Загрузка...
Treatment of Diffuse Large B Cell Lymphoma
Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in all countries and all age groups. DLBCL is potentially curable, and the outcome of patients with DLBCL has completely changed with the introduction of therapy involving the monoclonal antibody rituximab in co...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Association of Internal Medicine
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3529233/ https://ncbi.nlm.nih.gov/pubmed/23269875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2012.27.4.369 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|